Zivo Bioscience, Inc.
ZIVO
$17.76
$1.7611.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 185.71% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 185.71% | -- | |||
| Cost of Revenue | 185.07% | -- | |||
| Gross Profit | 184.21% | -- | |||
| SG&A Expenses | -28.98% | -67.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.41% | -72.16% | |||
| Operating Income | 29.36% | 72.54% | |||
| Income Before Tax | 29.41% | 72.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.41% | 72.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.41% | 72.46% | |||
| EBIT | 29.36% | 72.54% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 32.08% | 76.08% | |||
| Normalized Basic EPS | 32.07% | 76.08% | |||
| EPS Diluted | 32.08% | 76.08% | |||
| Normalized Diluted EPS | 32.07% | 76.08% | |||
| Average Basic Shares Outstanding | 3.92% | 15.15% | |||
| Average Diluted Shares Outstanding | 3.92% | 15.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||